Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 2,190.00
+20.00 (0.92%)
At close: Feb 27, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 205.98 billion as of February 27, 2026. Its market cap has increased by 88.44% in one year.
Market Cap
205.98B
Enterprise Value
187.77B
Revenue
12.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,190.00
Market Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 205.98B, an increase of 59.27%. That is a compound annual growth rate of 4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 205.98B | -5.60% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 313.55B |
| Bio Solution | 239.31B |
| Genome & Company | 235.53B |
| ISU Abxis | 226.81B |
| Prestige Biologics | 220.04B |
| Vaxcell-Bio Therapeutics | 220.01B |
| QuadMedicine | 214.37B |
| Ensol Biosciences | 199.94B |